The other side of the story

The evolving landscape of COVID-19 treatments

the other side of the storyRight now, vaccines are still claiming the majority of public attention – but safe and effective treatments are a critical weapon in our battle against COVID-19, offering hope of turning a potentially fatal virus into an inherently manageable one.

Although only a few treatments have been approved for use so far, the COVID-19 therapy development space is a hive of activity, with numerous manufacturers working on repurposing existing drugs and innovating new treatments.

In this article, we explore the focus for COVID-19 treatment development, the current COVID-19 treatment landscape and, drawing on real-world data from Ipsos’ new COVID-19 Therapy Monitor, how treatments are being used in real-world clinical practice.

 

 

Download

Related news

  • [Webinar] KEYS: Global Trends - The Uneasy Decade
    Global Trends Events replay

    [Webinar] KEYS: Global Trends - The Uneasy Decade

    At the next episode of our KEYS webinar, the Ipsos Global Trends team will be launching the findings of our latest report. This 9th edition explores how the trends that will shape the future are evolving, as the uneasy decade continues.
  • [Webinar] KEYS: Uncharted Territory
    Economy Events replay

    [Webinar] KEYS: Uncharted Territory

    The next episode of our KEYS webinar series is dedicated to what we’ve learned so far during 2025. Are we adapting fast enough? And are there areas where we need to change course?
  • [Webinar] KEYS: Tech-celeration
    Technology Events replay

    [Webinar] KEYS: Tech-celeration

    At our next KEYS webinar, we’ll be taking a moment to assess the role technology plays in today’s environment. What’s changing. And what’s staying the same?